Dr. Lin has over 10 years of clinical pharmacology experience with global pharmaceutical companies, including at Novartis Pharmaceuticals, Bayer Healthcare and Hoffmann-La Roche. Dr. Lin was a clinical pharmacology functional lead on study and development teams, with a therapeutic area focus in oncology. Dr. Lin is well versed in global development strategy from early to late-stage, and has interacted with health authorities in all key jurisdictions. Dr. Lin has supported numerous successful IND and NDA submissions, including successful global submissions of two oncology compounds with multiple indications.
Director, Integrated Drug Development